Ysios Capital
Overview
Ysios Capital is a life sciences venture capital firm that provides private equity financing to early- and mid-stage, highly innovative biotech companies developing novel therapies for indications with high unmet medical needs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mineralys Therapeutics | Feb 2023 | IPO | Co-investor |
| Galecto Biotech | Sep 2020 | Series D | Co-investor |
| Vivet Therapeutics | May 2017 | Series A | Co-investor |
| Adcendo | Apr 2026 | Series C | Co-investor |
| AM-Pharma | Mar 2020 | Series E Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
Julia Salaverria
Managing Partner
Karen Wagner
General Partner
Pamela Klein
Venture Partner
Arturo Urrios
Partner
Guillem Laporta
Partner
Jordi Xiol
Partner
Thomas Harth
Partner
Cristina Garmendia Mendizábal
Founding Partner and Member of the Board
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ysios Capital based?
Ysios Capital is headquartered in Barcelona, Spain.
When was Ysios Capital founded?
Ysios Capital was founded in 2008.
How many portfolio companies does Ysios Capital have?
Ysios Capital has 27 portfolio companies in Caplight's dataset.
What are some companies in Ysios Capital's portfolio?
Portfolio companies visible on Caplight include Mineralys Therapeutics, Galecto Biotech, Vivet Therapeutics, Adcendo, AM-Pharma.
What was Ysios Capital's most recent investment shown here?
Ysios Capital's most recent investment in this portfolio sample was in Adcendo in 2026.
What sectors does Ysios Capital focus on?
Ysios Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Enterprise Software.
What company stages does Ysios Capital focus on?
Ysios Capital typically invests at the MultiStage stage.
What is Ysios Capital's AUM?
Ysios Capital's assets under management are estimated between $250.0M and $500.0M.